Dr. Alberto Broniscer, MD
Claim this profileChildren's Hospital of Pittsburgh
Studies Brain Tumor
Studies Medulloblastoma
6 reported clinical trials
12 drugs studied
Area of expertise
1Brain Tumor
H3K27M positive
Stage III
Stage IV
2Medulloblastoma
MYC negative
CTNNB1 positive
MET positive
Affiliated Hospitals
Clinical Trials Alberto Broniscer, MD is currently running
Savolitinib
for Brain Tumors
This phase I trial studies the side effects and best dose of volitinib in treating patients with primary central nervous system (CNS) tumors that have come back (recurrent) or does not respond to treatment (refractory). Volitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 1
Pembrolizumab
for Pediatric Brain Cancer
This trial studies the safety and effectiveness of pembrolizumab in younger patients with aggressive or treatment-resistant brain tumors. Pembrolizumab is an immunotherapy drug that helps the immune system attack cancer by blocking a protein that stops immune cells from working effectively. Pembrolizumab has been used in various cancers, showing effective antitumor activity and is approved by the FDA for multiple uses.
Recruiting1 award Phase 124 criteria
More about Alberto Broniscer, MD
Clinical Trial Related8 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Alberto Broniscer, MD has experience with
- Dabrafenib
- Trametinib
- Hydroxychloroquine
- Panobinostat
- CX-4945
- Pembrolizumab
Breakdown of trials Alberto Broniscer, MD has run
Brain Tumor
Medulloblastoma
Diffuse Intrinsic Pontine Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alberto Broniscer, MD specialize in?
Alberto Broniscer, MD focuses on Brain Tumor and Medulloblastoma. In particular, much of their work with Brain Tumor has involved H3K27M positive patients, or patients who are Stage III.
Is Alberto Broniscer, MD currently recruiting for clinical trials?
Yes, Alberto Broniscer, MD is currently recruiting for 3 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Alberto Broniscer, MD has studied deeply?
Yes, Alberto Broniscer, MD has studied treatments such as Dabrafenib, Trametinib, Hydroxychloroquine.
What is the best way to schedule an appointment with Alberto Broniscer, MD?
Apply for one of the trials that Alberto Broniscer, MD is conducting.
What is the office address of Alberto Broniscer, MD?
The office of Alberto Broniscer, MD is located at: Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15224 United States. This is the address for their practice at the Children's Hospital of Pittsburgh.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.